○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (6) ✓ EMA GMP (4) ○ MHRA GMP

Quick Facts: ProBioGen

Signal Score
78.1/100 (as of 2026-10-29)
Quality Compliance
100.0/100 — Clean EMA record: 4 active GMP certificates (no deductions)
Headquarters
Berlin, DE
Modalities
AAV, Lentiviral, Biologics
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About ProBioGen

German CDMO specializing in cell line development and viral vectors.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Clean EMA record: 4 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 4 active GMP certificates (no deductions)
FDA InspectionsNo US records on file
EMA GMP Certificates4 on record
Clean EMA record: 4 active GMP certificates (no deductions)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Berlin, Germany
Modalities: AAV, Lentiviral, Biologics
Capacity assessment: 58.0/100
Sites: Berlin, Germany
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals6 articles (not scored)
1 manufacturing site: Berlin, Germany
Modalities: AAV, Lentiviral, Biologics
Capacity assessment: 58.0/100

ProBioGen EMA GMP Compliance 4 certificates

2026-08
2025-10
2025-10
2023-06
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DE_BE_01_GMP_2026_0044 ProBioGen AG Germany 2026-08-27 COMPLIANT
DE_BE_01_GMP_2025_0071 ProBioGen AG Germany 2025-10-01 COMPLIANT
DE_BE_01_GMP_2026_0043 ProBioGen AG Germany 2025-10-01 COMPLIANT
DE_BE_01_GMP_2025_0045 ProBioGen AG Germany 2023-06-09 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Company Signals 6 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-04-24
Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth - Manufacturing Chemist
Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth  Manufacturing Chemist
general 2026-04-22
Simon Bulling joins ProBioGen as COO - The Pharma Letter
Simon Bulling joins ProBioGen as COO  The Pharma Letter
regulatory 2026-04-22
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer - Indian Pharma Post
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer  Indian Pharma Post
regulatory 2026-04-22
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion - Indian Pharma Post
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion  Indian Pharma Post
regulatory 2026-04-22
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer - Indian Pharma Post
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer  Indian Pharma Post
regulatory 2026-04-21
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion - Indian Pharma Post
ProBioGen qppoints biopharma veteran Simon Bulling as COO to drive next phase of global expansion  Indian Pharma Post

Frequently Asked Questions About ProBioGen

Does ProBioGen hold EMA or MHRA GMP certificates?
CDMO Signal tracks 4 EMA GMP certificates for ProBioGen.
What is ProBioGen's CDMO Signal Score?
ProBioGen has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating ProBioGen for a manufacturing program?
Use the free AI matchmaker to compare ProBioGen against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs → Biologics CDMOs →

Similar CDMOs

BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
Ascend Advanced Therapies
Rockville, MD · Alachua, FL · Munich, DE
Signal Score: 78.1
AAV, Lentiviral, Plasmid
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC

Compare ProBioGen with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on ProBioGen
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.